Global CRISPR Research Report 2023: The Future of Revolutionary Gene Editing Technology - Changing the Landscape of Healthcare and Biotechnology
August 03, 2023 05:13 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Global CRISPR Market by Product (Enzymes, Kits, Libraries), Services (gRNA Design, Cell Line Engineering, Screening), Application (Drug Discovery &...
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
July 24, 2023 09:49 ET
|
GreenLight Biosciences
LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced the closing of its previously announced...
France Gene Editing Technology Business and Investment Opportunities 2023: A $532.2 Million Market by 2027
June 28, 2023 04:08 ET
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "France Gene Editing Technology Databook 2023" has been added to ResearchAndMarkets.com's offering.France's gene editing technology market is forecast...
UAE Gene Editing Technology Databook 2023: Compound Annual Growth of 8.4% Forecast During 2023-2027
June 13, 2023 04:03 ET
|
Research and Markets
Dublin, June 13, 2023 (GLOBE NEWSWIRE) -- The "UAE Gene Editing Technology Databook 2023" has been added to ResearchAndMarkets.com's offering.The UAE gene editing technology market is expected to...
ALERT: The M&A Class Action Firm Continues Investigating the Merger – VKIN, GRNA, FRG, AAIC
June 07, 2023 16:54 ET
|
Monteverde & Associates PC
NEW YORK, June 07, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
ALERT: The M&A Class Action Firm Continues Investigating the Merger – FRG, GRNA, EMBK, AAIC
May 31, 2023 16:51 ET
|
Monteverde & Associates PC
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
India Gene Editing Technology Market Databook Report 2023-2027: CRISPR, Meganucleases, TALEN, and ZFN Products, Delivery Method, Disease/Disorders, and Applications
March 03, 2023 06:58 ET
|
Research and Markets
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "India Gene Editing Technology Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's...
China Gene Editing Technology Market Databook Report 2023: Business and Investment Opportunities to 2027
February 27, 2023 10:33 ET
|
Research and Markets
Dublin, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The "China Gene Editing Technology Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's...
CRISPR Technology Global Markets Report 2023: A $9.2 Billion Market by 2027, from $3.3 Billion in 2022
January 25, 2023 04:08 ET
|
Research and Markets
Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "CRISPR Technology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report provides detailed exposure to the...
Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrument
October 19, 2022 09:00 ET
|
Telesis Bio
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, and Cellibre, a leading manufacturing technology company,...